Treatment Registry

Compare

HealthRX and Zealthy

What each charges for compounded semaglutide. Each program below shows its own form, terms and source date. The recorded price bases differ or an initial payment is unverified; no like-for-like initial-cost difference is calculated. Payment terms, forms and doses differ, so read the full records before treating the figures as equivalent.

Side by side

HealthRX

$133

Published figure · initial payment not verified

Injection, vial

◯ $133 advertised · 3-month plan

MembershipNone. “There are no separate visit fees or membership fees.”
Consultation feeNone. “There are no separate visit fees or membership fees.”
PharmacyNot yet checked
Terms published2 (payment not verified)

“Compounded Semaglutide Once-weekly injection · GLP-1 The most-studied GLP-1 compound. Average 15% body-weight loss at 68 weeks in STEP-1 trial. Compounded at a licensed 503A pharmacy. FROM $133 /mo (3-month plan) · as low as $99/mo on 12-month”

Read on healthrx.com, September 2026 · Full record TR-0376

Enroll with HealthRX

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

Zealthy

$336

first month, including required fees on record

Form not recorded

◯ $297 advertised · Doctor + GLP-1 bundle

MembershipRequired, $39 per month
Consultation feeNot disclosed as of August 2026
PharmacyNot disclosed as of August 2026
Terms published2 (1 month, 3 months)

“Limited time: $297/month Doctor + Medication (+$80 off first month)”

Read on getzealthy.com, September 2026 · Full record TR-0027

Visit Zealthy

We earn nothing from this link. It opens Zealthy's website without a paid referral.

Notes

Neither company is recommended here. This page records published program prices with the dates they were read, and adds the charges each company states are required. What suits you depends on dose, terms, and clinical fit, none of which a price comparison can settle. See what this record is and is not.

Other comparisons